High Stakes Direct to Consumer Marketing of Unproven Stem Cell Treatments for Lung Disease

Overview of attention for article published in CHEST, June 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 49,320 followers.

High stakes indeed! Editorial in this month’s @accpchest CHEST Journal on the dangers of the massive expansion in stem cell treatment with little standardization or IRB monitoring by practitioners with stem cell experience #PulmCC https://t.co/qFblNnv5fv

Direct-to-consumer marketing of unproven stem cell treatments for lung disease. #journalCHEST https://t.co/XFlFOdwlnG

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.